Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus Titration Algorithm vs. Standard Practice in Type 2 Diabetes
NCT00627471Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jan 2008
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jan 2008; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00627471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627471.